Lansdale, PA, United States of America

Jeffrey C Pelletier

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 84(Granted Patents)


Company Filing History:


Years Active: 1990-1994

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Jeffrey C. Pelletier

Introduction

Jeffrey C. Pelletier is a notable inventor based in Lansdale, PA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Pelletier has made strides in developing innovative solutions for medical challenges.

Latest Patents

Among his latest patents, Pelletier has developed antithrombotic peptides and pseudopeptides. This invention focuses on novel peptide and pseudopeptide derivatives and analogs of aspartic acid, which serve as inhibitors of platelet aggregation and thrombus formation in mammalian blood. Additionally, he has created substituted saturated and unsaturated indole quinoline and benzazepine compounds. These compounds are designed to treat patients suffering from gastrointestinal disorders and include pharmaceutical compositions with effective 5HT3-antagonist amounts.

Career Highlights

Throughout his career, Pelletier has worked with prominent companies such as Rorer Pharmaceutical Corporation and Rhone-Poulenc Rorer Pharmaceuticals Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Pelletier has collaborated with notable individuals in the field, including Raymond D. Youssefyeh and Henry F. Campbell. These partnerships have further enhanced his innovative efforts and contributions to the industry.

Conclusion

Jeffrey C. Pelletier's work exemplifies the impact of innovation in pharmaceuticals, particularly in developing treatments that address critical health issues. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…